Abstract
Non-canonical EGFR mutations in non-small cell lung cancer (NSCLC) could be re-classified into four subtypes (Classical-like, P-loop and αC-helical compressing (PACC), T790M-like, and exon 20 loop insertions) based on unique structures as well as response to various types of tyrosine kinase inhibitors (TKIs). Since EGFR most frequently mutated in East-Asian population, it is clinically crucial to investigate the distribution of structure-based EGFR classification in Chinses NSCLC patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have